RPL13 (eL13) is an integral structural component of the 60S large ribosomal subunit that is required for proper ribosome assembly and global translation (PMID:32916022, PMID:7557437). Disease-causing mutations do not destabilize the protein or its incorporation into 60S subunits, but reduce its colocalization with the partner protein eL28, elevate the ratio of 60S subunits to mature 80S ribosomes, and attenuate global translation, indicating a defect in subunit joining or ribosome maturation rather than in protein expression (PMID:32916022). Splice variants that introduce an 18-amino-acid insertion are likewise stably expressed and incorporated into 60S subunits yet alter ribosome profiles and erythroid proliferation, consistent with changed translation dynamics (PMID:31630789). Beyond its core ribosomal role, RPL13 is highly expressed in chondrocytes and osteoblasts of the growth plate and is required for skeletogenesis in vivo, as rpl13-mutant zebrafish develop cartilage deformities (PMID:31630789, PMID:32916022); it is also required for cardiogenesis, with knockdown impairing cardiomyocyte proliferation and differentiation in human iPSC-derived progenitors and producing a 'no heart' phenotype in Drosophila (PMID:31625562). These tissue-specific requirements underlie the skeletal dysplasia SEMD-RPL13, in which causative variants cluster within an RNA-binding motif (PMID:32916022, PMID:37993442). Whether RPL13 carries out extra-ribosomal mRNA-binding functions has not been experimentally established in the available corpus.